Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Jordan

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
The Journal of Infectious Diseases|December 7, 2019
Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical ImpactHerbert A Mbunkah, Silvia Bertagnolio, Raph L Hamers, et al.
Viruses|March 28, 2024
Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping ReviewCarolyn Chu, Kaiming Tao, Vinie Kouamou, et al.
AIDS (London, England)|September 27, 2023
First case report of a perinatally HIV-infected infant with HIV resistance to dolutegravir associated with tenofovir/lamivudine/dolutegravir use in mothersKesner Francois, Joelle Deas Van Onacker, Michael R Jordan, et al.
AIDS Research and Treatment|July 22, 2011
Predictors of Weight Change in Male HIV-Positive Injection Drug Users Initiating Antiretroviral Therapy in Hanoi, VietnamAlice M Tang, Heidi B Sheehan, Michael R Jordan, et al.
Lancet (London, England)|July 26, 2012
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysisRavindra K Gupta, Michael R Jordan, Binta J Sultan, et al.
Plos One|June 14, 2013
HIV drug resistance early warning indicators in Namibia for public health actionAnna Jonas, Justice Gweshe, Milner Siboleka, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 15, 2010
Population-based monitoring of HIV drug resistance in Namibia with early warning indicatorsSteven Y Hong, Anna Jonas, Efraim Dumeni, et al.
BMJ Global Health|August 2, 2022
HIV and SARS-CoV-2: the interplay of two wicked problemsAnneleen Kiekens, George Msema Bwire, Catherine Decouttere, et al.
Viruses|February 28, 2023
HIV Drug Resistance in Adults Initiating or Reinitiating Antiretroviral Therapy in Uruguay-Results of a Nationally Representative Survey, 2018-2019Rosa Flieller, Susana Cabrera, Dora Ruchansky, et al.
AIDS (London, England)|March 7, 2025
Noncanonical HIV drug resistance mutations: need to close existing gapsSeth Inzaule, Michael R Jordan, Joseph Fokam, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
The Journal of Infectious Diseases|December 7, 2019
Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical ImpactHerbert A Mbunkah, Silvia Bertagnolio, Raph L Hamers, et al.
Viruses|March 28, 2024
Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping ReviewCarolyn Chu, Kaiming Tao, Vinie Kouamou, et al.
AIDS (London, England)|September 27, 2023
First case report of a perinatally HIV-infected infant with HIV resistance to dolutegravir associated with tenofovir/lamivudine/dolutegravir use in mothersKesner Francois, Joelle Deas Van Onacker, Michael R Jordan, et al.
AIDS Research and Treatment|July 22, 2011
Predictors of Weight Change in Male HIV-Positive Injection Drug Users Initiating Antiretroviral Therapy in Hanoi, VietnamAlice M Tang, Heidi B Sheehan, Michael R Jordan, et al.
Lancet (London, England)|July 26, 2012
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysisRavindra K Gupta, Michael R Jordan, Binta J Sultan, et al.
Plos One|June 14, 2013
HIV drug resistance early warning indicators in Namibia for public health actionAnna Jonas, Justice Gweshe, Milner Siboleka, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 15, 2010
Population-based monitoring of HIV drug resistance in Namibia with early warning indicatorsSteven Y Hong, Anna Jonas, Efraim Dumeni, et al.
BMJ Global Health|August 2, 2022
HIV and SARS-CoV-2: the interplay of two wicked problemsAnneleen Kiekens, George Msema Bwire, Catherine Decouttere, et al.
Viruses|February 28, 2023
HIV Drug Resistance in Adults Initiating or Reinitiating Antiretroviral Therapy in Uruguay-Results of a Nationally Representative Survey, 2018-2019Rosa Flieller, Susana Cabrera, Dora Ruchansky, et al.
AIDS (London, England)|March 7, 2025
Noncanonical HIV drug resistance mutations: need to close existing gapsSeth Inzaule, Michael R Jordan, Joseph Fokam, et al.
Pageof 11